The unequal distribution of COVID-19 vaccines has left 80 percent of global vaccine stocks in the hands of just 10 countries.
This situation was exacerbated by the administration of former US president Donald Trump, which last year attempted to withdraw from the WHO.
This opened a political vacuum that China immediately filled, allowing Beijing to engage in “vaccine diplomacy,” enhance its soft power and promote Chinese President Xi Jinping’s (習近平) vision of a Chinese “community of shared human destiny.”
Beijing used its vaccine diplomacy to project China as an ethical force for good, as opposed to “selfish” Western nations, which stockpiled vaccines for themselves. The Chinese Communist Party sought to build a narrative that China was working to provide every country access to COVID-19 vaccines, as a public commodity.
Using this message, Beijing was able to shift attention toward production capacity and distribution, and away from the efficacy of the vaccines in inoculating people against the disease.
Is China really more benevolent than Western nations?
According to US research, China only donated a small quantity of vaccines to specific markets or nations for trial purposes. Most Chinese vaccines were sold, not donated, to foreign nations.
A research paper published by Springer Nature titled “Vaccine diplomacy: nation branding and China’s COVID-19 soft power play” shows that of the 656 million doses of COVID-19 vaccine Chinese pharmaceutical companies exported to foreign nations at the time of the study, only 8.6 million, or 1.31 percent, were donated; the rest were sold.
Moreover, most sales have been concentrated in Latin American, Southeast Asian and African nations. Since most of these countries lack robust cold chain storage technology, China’s inactivated virus vaccines were more attractive than Western messenger ribonucleic acid — known as mRNA — vaccines, since inactivated virus vaccines are easier to store, requiring only conventional refrigeration.
Sinovac’s CoronaVac vaccine retails for US$13.60 per shot, while the most expensive of China’s COVID-19 vaccines sell for US$60 per shot. Compared with US$4 per shot for the AstraZeneca vaccine, China’s offerings are considerably more expensive.
For simplicity, if China sold the CoronaVac vaccine at US$13.60 per shot, it made US$8.8 billion from export sales through this one vaccine.
While other countries have donated vaccines to the COVAX scheme, China has sold its vaccines to the program. Beijing has also provided economically weak nations with loans to purchase its vaccines, using every available opportunity to make money from the crisis.
China is quietly lining its pockets, yet has the temerity to criticize Western nations and cast itself as the savior of the world.
Yang Chun-chieh is a graduate student at National Tsing-Hua University’s Institute of Sociology.
Translated by Edward Jones
Saudi Arabian largesse is flooding Egypt’s cultural scene, but the reception is mixed. Some welcome new “cooperation” between two regional powerhouses, while others fear a hostile takeover by Riyadh. In Cairo, historically the cultural capital of the Arab world, Egyptian Minister of Culture Nevine al-Kilany recently hosted Saudi Arabian General Entertainment Authority chairman Turki al-Sheikh. The deep-pocketed al-Sheikh has emerged as a Medici-like patron for Egypt’s cultural elite, courted by Cairo’s top talent to produce a slew of forthcoming films. A new three-way agreement between al-Sheikh, Kilany and United Media Services — a multi-media conglomerate linked to state intelligence that owns much of
The US and other countries should take concrete steps to confront the threats from Beijing to avoid war, US Representative Mario Diaz-Balart said in an interview with Voice of America on March 13. The US should use “every diplomatic economic tool at our disposal to treat China as what it is... to avoid war,” Diaz-Balart said. Giving an example of what the US could do, he said that it has to be more aggressive in its military sales to Taiwan. Actions by cross-party US lawmakers in the past few years such as meeting with Taiwanese officials in Washington and Taipei, and
The Republic of China (ROC) on Taiwan has no official diplomatic allies in the EU. With the exception of the Vatican, it has no official allies in Europe at all. This does not prevent the ROC — Taiwan — from having close relations with EU member states and other European countries. The exact nature of the relationship does bear revisiting, if only to clarify what is a very complicated and sensitive idea, the details of which leave considerable room for misunderstanding, misrepresentation and disagreement. Only this week, President Tsai Ing-wen (蔡英文) received members of the European Parliament’s Delegation for Relations
Denmark’s “one China” policy more and more resembles Beijing’s “one China” principle. At least, this is how things appear. In recent interactions with the Danish state, such as applying for residency permits, a Taiwanese’s nationality would be listed as “China.” That designation occurs for a Taiwanese student coming to Denmark or a Danish citizen arriving in Denmark with, for example, their Taiwanese partner. Details of this were published on Sunday in an article in the Danish daily Berlingske written by Alexander Sjoberg and Tobias Reinwald. The pretext for this new practice is that Denmark does not recognize Taiwan as a state under